Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma.

Wang Z, Wei Y, Zhang R, Su L, Gogarten SM, Liu G, Brennan P, Field JK, McKay JD, Lissowska J, Swiatkowska B, Janout V, Bolca C, Kontic M, Scelo G, Zaridze D, Laurie CC, Doheny KF, Pugh EK, Marosy BA, Hetrick KN, Xiao X, Pikielny C, Hung RJ, Amos CI, Lin X, Christiani DC.

EBioMedicine. 2018 Jun;32:93-101. doi: 10.1016/j.ebiom.2018.05.024. Epub 2018 May 31.

2.

Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.

Zhen Q, Liu JF, Liu JB, Wang RF, Chu WW, Zhang YX, Tan GL, Zhao XJ, Lv BL.

Cancer Biol Ther. 2015;16(4):549-57. doi: 10.1080/15384047.2015.1016689. Epub 2015 Apr 1.

3.

The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

Putra AC, Eguchi H, Lee KL, Yamane Y, Gustine E, Isobe T, Nishiyama M, Hiyama K, Poellinger L, Tanimoto K.

PLoS One. 2015 Aug 11;10(8):e0134496. doi: 10.1371/journal.pone.0134496. eCollection 2015.

4.

Prognostic potential of DNA methylation and transcript levels of HIF1A and EPAS1 in colorectal cancer.

Rawłuszko-Wieczorek AA, Horbacka K, Krokowicz P, Misztal M, Jagodziński PP.

Mol Cancer Res. 2014 Aug;12(8):1112-27. doi: 10.1158/1541-7786.MCR-14-0054. Epub 2014 May 13.

5.

Association of EPAS1 gene rs4953354 polymorphism with susceptibility to lung adenocarcinoma in female Japanese non-smokers.

Iwamoto S, Tanimoto K, Nishio Y, Putra AC, Fuchita H, Ohe M, Sutani A, Kuraki T, Hiyama K, Murakami I, Eguchi H, Isobe T.

J Thorac Oncol. 2014 Nov;9(11):1709-13. doi: 10.1097/JTO.0000000000000309.

6.

Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.

Kuo WH, Shih CM, Lin CW, Cheng WE, Chen SC, Chen W, Lee YL.

Transl Res. 2012 Jan;159(1):42-50. doi: 10.1016/j.trsl.2011.09.003. Epub 2011 Oct 8.

PMID:
22153809
8.

Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.

Oleksiewicz U, Liloglou T, Tasopoulou KM, Daskoulidou N, Bryan J, Gosney JR, Field JK, Xinarianos G.

Hum Mol Genet. 2013 Aug 15;22(16):3207-17. doi: 10.1093/hmg/ddt174. Epub 2013 Apr 15.

PMID:
23591990
9.

Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.

Yang SL, Ren QG, Wen L, Hu JL.

J Huazhong Univ Sci Technolog Med Sci. 2016 Jun;36(3):321-327. doi: 10.1007/s11596-016-1586-7. Epub 2016 Jul 5. Review.

PMID:
27376798
10.

Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines.

Liu YL, Yu JM, Song XR, Wang XW, Xing LG, Gao BB.

Cancer Biol Ther. 2006 Oct;5(10):1320-6. Epub 2006 Oct 4.

PMID:
16929169
11.

Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.

Dötsch MM, Kloten V, Schlensog M, Heide T, Braunschweig T, Veeck J, Petersen I, Knüchel R, Dahl E.

Epigenetics. 2015;10(10):903-12. doi: 10.1080/15592294.2015.1078049. Epub 2015 Aug 7.

12.

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.

Maeda A, Nakata M, Yasuda K, Yukawa T, Saisho S, Okita R, Hirami Y, Shimizu K.

Oncol Rep. 2013 Jan;29(1):39-44. doi: 10.3892/or.2012.2075. Epub 2012 Oct 9.

13.

Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer.

Chen YQ, Zhao CL, Li W.

J Exp Clin Cancer Res. 2009 Feb 26;28:29. doi: 10.1186/1756-9966-28-29.

14.

Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers.

Fang X, Yin Z, Li X, Xia L, Quan X, Zhao Y, Zhou B.

Oncotarget. 2017 Mar 21;8(12):18924-18934. doi: 10.18632/oncotarget.14836.

15.
16.
17.

Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.

Yeo MK, Choi SY, Seong IO, Suh KS, Kim JM, Kim KH.

Hum Pathol. 2017 Oct;68:103-111. doi: 10.1016/j.humpath.2017.08.016. Epub 2017 Aug 26.

PMID:
28851662
18.

HIF-2α not HIF-1α overexpression confers poor prognosis in non-small cell lung cancer.

Gao ZJ, Wang Y, Yuan WD, Yuan JQ, Yuan K.

Tumour Biol. 2017 Jun;39(6):1010428317709637. doi: 10.1177/1010428317709637.

PMID:
28653893
19.
20.

Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.

Putra AC, Tanimoto K, Arifin M, Hiyama K.

Respirology. 2011 Jul;16(5):796-802. doi: 10.1111/j.1440-1843.2011.01972.x.

PMID:
21435097

Supplemental Content

Support Center